Sort By First Letter of Last Name
Edward B. Diethrich, MD
Arizona Heart Foundation2015 BOARD OF DIRECTORS
Founder International Society of Endovascular Specialists
Founder International Society of Endovascular Specialists
Dr. Edward B. Diethrich, an internationally renowned cardiovascular surgeon who has practiced for more than 40 years, is regarded as one of the world’s pioneers in heart disease diagnosis and innovative cardiovascular and endovascular treatments.
In 1971, Dr. Diethrich founded the Arizona Heart Institute and Foundation the nation’s first freestanding outpatient clinic devoted solely to the prevention, diagnosis and treatment of heart and blood vessel disease.
Dr. Diethrich is the Medical Director and Chief of Cardiovascular Surgery at the Arizona Heart Hospital, where he performs state-of-the art cardiovascular and endovascular procedures using the latest devices, many of which he helped design and test in clinical trials.
Dr. Diethrich’s professional accomplishments are diverse and include the development of the sternal saw used for open chest surgery and the establishment of the nation’s first outpatient cardiac catheterization laboratory. An advocate for patient education, Dr. Diethrich appears weekly on a television news program answering call-in questions and is interviewed frequently by the media.
A graduate of the University of Michigan Medical School, Dr. Diethrich did his surgical residency training at St. Joseph’s Mercy Hospital and University of Michigan in Ann Arbor and Henry Ford Hospital in Detroit. After completing a two-year thoracic and cardiovascular surgery residency at Baylor College of Medicine under the tutelage of famed heart surgeon, Dr. Michael E. DeBakey and Dr. Denton Cooley, he remained at Baylor as assistant professor in surgery for six years.
Dr. Diethrich is board certified in general, thoracic and cardiovascular surgery, and is a fellow of the American Colleges of Angioplasty, Cardiology, Surgery, Chest Physicians and the International College of Angioplasty. He is a member of numerous societies such as the Michael E. DeBakey International Cardiovascular Society, the Denton A. Cooley Cardiovascular Surgical Society, Society of Academic Surgeons, and is Council on Cardiovascular Disease for the American Heart Association. He is also a past president and current chairman of the Board of Directors of the International Society of Endovascular Specialists. An active member of the interventional medicine community, he belongs to more than 25 organizations, has received numerous awards and has authored several books and hundreds of scientific articles.
He lectures and operates worldwide teaching many of the procedures developed at the Arizona Heart Institute. He provides consultation and second opinion services in addition to his operative work in all areas of cardiovascular surgery and intervention.
Dr. Diethrich is an enthusiastic educator and an advanced scientific researcher. He is the Scientific Director of the new Arizona Heart Institute Translational Research Center. In that capacity, he guides the Institute’s investigative progress and assures that the Institute and Arizona Heart Hospital will always be on the cutting edge of cardiovascular scientific innovations, advanced patient care and human applications.
Grayson H. Wheatley, III, MD
Temple University School of Medicine2015 BOARD OF DIRECTORS
Dr. Wheatley earned his Bachelor of Science in Mathematics from Florida State University and his medical degree from Jefferson Medical College of Thomas Jefferson University. He completed his General Surgery Residency at Ohio State University, where he was awarded the Department of Surgery Teaching Award 2001. Dr. Wheatley was one of only four selected residents, from all of the resident house staff, to be awarded the Excellence in Teaching Award by the graduating medical school class of 2001 of Ohio State University.
Dr. Wheatley completed a two year NIH sponsored research fellowship with the Department of Surgery at Duke University Medical Center. He completed a three year residency in Cardiothoracic Surgery at the University Of Texas Southwestern Medical Center in Dallas. Dr. Wheatley is a former President of the Thoracic Surgery Residents Association, is currently a member of the Society of Thoracic Surgeons (STS) Endovascular Task Force and Course Co-Director of the STS Thoracic Endovascular Symposium. He was the 2001-2005 Chair of the Organization of Resident Representatives of the American Association of Medical Colleges. Author of numerous journal articles and a frequent conference presenter, Dr. Wheatley has a special interest in cardiovascular surgery, minimally invasive cardiovascular surgery, valve repair, in addition to resident and student education.
Clifford J. Buckley, MD
Scott & White Clinic and Hospital2015 BOARD OF DIRECTORS
Dr. Buckley has 16 years of service with both line operations and the Medical Service of the US Air Force; serving as Program Director for the largest Surgical Residency in the United States military. He also spent 15 years in the private practice of vascular surgery in San Antonio, Texas. He is involved in both the teaching and practice of vascular surgery at Baylor Scott & White Hospital and the Central Texas Veterans Health Care System in Temple, TX.
Dr. Buckley is a member of many prestigious professional organizations. He is a Fellow of the American College of Surgeons, a Distinguished Fellow of the Society for Vascular Surgery, the International Society of Endovascular Specialists and the Texas Surgical Society, to name but a few. He is a Past President of the Texas Surgical Society. He is President-Elect of the International Society of Endovascular Specialists.
Dr. Buckley is actively engaged in research. He is currently the local PI for the Endologix EVAS I study. He has also served as local PI for many device studies conducted by Endologix, Medtronic, Gore and Cook. His other research interests involve arterial and venous disease of the lower extremities.
Dr. Buckley has authored over 70 peer-reviewed articles, 6 book chapters and twice served as Co-Guest Editor for Seminars in Vascular Surgery.
Jacques Busquet, MD
Clinique Chirugicale Val D’or2015 BOARD OF DIRECTORS
Board International Representative
Board International Representative
Jacques Busquet, MD, is currently coordinator of vascular and endovascular service in the cardio-vascular department of the Clinique Chirurgicale Val d’Or - Saint Cloud, a prestigious private hospital in Paris, France, part of the Vivalto Foundation Group.
He completed medical school, four-year internship in surgery and six-year residency in cardio-vascular and thoracic surgery at the University of Bordeaux, France. In 1983, he also completed a cardio-vascular research fellowship at the Brompton Hospital, University of London, UK, after winning the research award of the French Society of Cardiology.
In 1988, he sets up one of the first endovascular program in France using peripheral angioplasty and stents, after several post-residency trainings in USA (Los Angeles, Phoenix, New Orleans). Since this time, he is actively involved as speaker, moderator or scientific committee member of the major international vascular and endovascular meetings (Arizona Heart, Charing Cross, CEC, CICE , CIT, EuroPCR, Ochsner, Mayo, SITE, TCT, VEITH, VERVE, VIVA). In November 2010, he received the international vascular award “Pionner in Performance” in New York City during Veith Symposium.
Dr Busquet is co-founder in 1992, executive board member and former chairman of international council of the International Society of Endovascular Specialists (ISEVS), a medical society having 1600 members and represented in 60 countries. He has been President of the Society from February 2011 to February 2013, succeeding Professor Christopher Zarins from Stanford University and has the current position of ISEVS International Ambassador.
He is also president of the Val d’Or Vascular Association, a french non-profit organization dedicated to research and development in cardiovascular medicine. Since 2006, under its auspices, he organizes annually in Paris a successful vascular meeting on vascular diseases, cardio-vascular imaging and endovascular technologies open to cardio-vascular specialists.
Dr Busquet is member of the French Society of Vascular Surgery, former elected board member from 2001 to 2008. He also serves as editorial board member in the Journal of Endovascular Therapy (USA), the Endovascular Today Magazine (USA), the Endovascular Today Magazine – Europe (USA) and Tecnicas Endovasculares (Spain).
His hobbies are reading, oenology and sport (marathon runner, former member of the french olympic sailing team). [ Dr Jacques BUSQUET can be reached at firstname.lastname@example.org ]
Zvonimir Krajcer, MD
Texas Heart Institute2015 BOARD OF DIRECTORS
St. Luke’s Episcopal Hospital
Board President Elect
Chairman Educational Committee
St. Luke’s Episcopal Hospital
Board President Elect
Chairman Educational Committee
Since 1996-Present Participated as co-investigator and principal investigator in many stent and stent graft trials for treatment of peripheral arterial disease, abdominal and thoracic aortic aneurysms (Corvita AAA trial, Hemobahn Trial, AneuRx AAA Trial, AneuRx Thoracic trial, Wallgraft Trial, Carotid Wallstent Trial, Sapphire Carotid Stent Trial, BEECH Carotid Trial, Sapphire World Registry Trial, Archer Carotid Stent Trial, Choice Carotid stent Trial, Capture I & II Carotid Stent Trials, Endologix EVAR Trials, Valor I and Valor II Trial, Captivia Thoracic Trial, Captivia Acute Dissection Trial, Excluder Original Design vs. Low Permeability Design study
1997 Present Participated as co-investigators at several carotid artery stenting trials
2010: Principal co Investigator of the PEVAR Trial: Percutaneous Abdominal Aortic Aneurysm repair versus surgical Femoral artery access and repair randomized and controlled trial
Marvin L. Woodall, BBA
Marwood Consulting, LLC2015 BOARD OF DIRECTORS
Board Executive Committee Consultant
Board Executive Committee Consultant
Mr. Marvin L. Woodall serves as the Chief Executive Officer at the Cardiovascular Research Foundation. Mr. Woodall is a Scientific Advisor at Boston Millennia Partners. Mr. Woodall served as the Vice President of Johnson & Johnson International, responsible for Health Economics Worldwide, for the Cordis circulatory disease business franchise from 1997 to 2000. He served as the President of Johnson & Johnson Interventional Systems, Inc., leading the team responsible for pioneering its cardiovascular franchise into a $1 billion division from 1988 to 1996. Mr. Woodall's distinguished career at Johnson & Johnson spanned nearly 37 years. His tenure there included the development and launch of the PALMAZ-SCHATZ® Coronary Stent. Mr. Woodall retired from Johnson & Johnson in 2001.
He serves as the Chairman of the Board at Prescient Medical, Inc. He served as the Chairman of the Board at Lehigh Valley Hospital and Health Network. Mr. Woodall is a Director at International Society of Endovascular Specialists and Icon Interventional Systems, Inc. He has been a Director of CardioMEMs, Inc., since April 2004. He serves as a Director of Contego Medical, LLC. He served as a Director of Percutaneous Valve Technologies, Inc. and the Cardiovascular Research Foundation. Mr. Woodall has served on the Board of Directors for Doylestown Hospital and Percutaneous Valve Technologies. He is an undergraduate with B.B.A. in Management and Finance from University of Oklahoma and Graduate Studies at Harvard, Columbia, and Duke Universities.
Frank J. Criado, MD
Medstar Union Memorial HospitalBOARD MEMBER
Dr. Frank J Criado is a Board-Certified Vascular Surgeon and Endovascular Specialist at MedStar Union Memorial Hospital in Baltimore, Maryland – USA. He trained in general surgery at MedStar Union Memorial in Baltimore 1975-80, and as a Fellow in Cardiovascular Surgery under Drs. Michael DeBakey and Stanley Crawford at Baylor College of Medicine-Methodist Hospital in Houston, Texas in the early 1980s.
Dr. Criado is widely recognized to be a pioneer and thought leader in endovascular therapy, and a major presence at most major vascular and endovascular congresses and events in the U.S. and around the world. He has contributed extensively to the literature with more than 170 publications – mostly on various vascular and endovascular subjects, and was the Editor-in-Chief of Vascular Disease Management (VDM) from its inception in 2004 until December 31, 2013.
Dr. Criado has been active in clinical research, with a major focus on aortic stent-graft and carotid interventions, and endovascular technologies in general. He was the U.S. National Principal Investigator (P.I.) for the Medtronic Talent AAA clinical trials, and a member of the Executive Committee for the Medtronic Valor and Valor II Thoracic TAA trials. Additionally, he has been a Site-Principal Investigator for many other clinical studies testing aortic endografts and carotid-stent systems.
He is a founding member and past President of the International Society of Endovascular Specialists (ISEVS), founder and past President of the Endovascular Surgery Society of Latinamerica (CELA), and a member of all major US and international vascular and endovascular societies. He is a Fellow of the American College of Surgeons (FACS) and a Fellow of the Society of Vascular Medicine (FSVM), and a former member of the Board of Directors (2007-2009) of the Society for Vascular Surgery (SVS).
Eric J. Dippel, MD
Genesis Heart InstituteBOARD MEMBER
Eric J. Dippel, M.D. is a private practice-based cardiovascular and peripheral vascular interventionist with Cardiovascular Medicine, P.C., Davenport, IA. and also is the President of Midwest Cardiovascular Research Foundation.
Dr. Dippel received his undergraduate degree with departmental honors in biomedical engineering from Northwestern University. He completed his medical school and Internal Medicine residency at the University of Iowa Hospital and Clinics. He completed his general fellowship in Cardiovascular Medicine at the University of Kansas Medical Center. An advanced fellowship in coronary and peripheral vascular intervention was completed at the Ohio Heart Health Center, and the University of Cincinnati.
Dr. Dippel is certified by the American Board of Internal Medicine in Cardiovascular Medicine, and Interventional Cardiology. He is a Fellow of the American College of Cardiology, and member of the American Heart Association Council of Clinical Cardiology, the American Medical Association, and the American College of Physicians.
Dr. Dippel’s research interests include: adjunctive pharmacology including anti-platelet and anti-thrombin therapy, vascular inflammation, endothelial function, and new devices. He has been the principle investigator in a number of clinical trials, presented abstracts and lectured at national meetings and international meetings, and published articles in journals such as Catheterization and Cardiovascular Intervention, the Journal of Invasive Cardiology, and the Journal of the American College of Cardiology.
In addition, Dr. Dippel has several patents pending for medical devices.
William Gray, MD
Center for Interventional Vascular TherapyBOARD MEMBER
William A. Gray, M.D., is an interventional cardiologist, board certified in internal medicine, cardiology, interventional cardiology, vascular medicine and endovascular medicine. Dr. Gray has been at the Center for Interventional Vascular Therapy (CIVT) as Director, Endovascular Intervention at New York Columbia-Presbyterian Hospital since 2005.
Prior to joining Columbia University Dr. Gray was Director of the Endovascular Care at Swedish Medical Center from 1999-2005. Before Seattle, Dr. Gray practiced at Southwest Cardiology where he directed research, served as vice-chair of the Cardiology division at Presbyterian Hospital in Albuquerque, N.M., and was a founding member of the Heart Hospital of New Mexico.
Dr. Gray specializes in cardiac/structural and peripheral arterial disease diagnosis and treatment with a special interest in new, non-surgical modalities for stroke prevention (carotid stenting and left atrial appendage occlusion devices), and research into preventing the reoccurrence of disease following successful angioplasty or stenting. He has also dedicated a significant portion of the past decade of his career to the non-surgical management of mitral regurgitation.
Dr. Gray has been principal investigator for numerous clinical trials, and is routinely asked to speak at national and international conferences. He has also been a consultant and device/procedure proctor for numerous medical corporations, and has been a journal reviewer for the Journal of the American Medical Association, the Journal of the American College of Cardiology, Circulation, and Catheterization and Cardiovascular Intervention.
Dr. Gray holds a bachelor’s degree in Chemistry from Dickinson College in Carlisle, PA and graduated from Temple University’s School of Medicine in Philadelphia. Dr. Gray’s postgraduate training included an internship, residency, and Chief Residency in Internal Medicine at Brown University/Rhode Island Hospital in Providence, R.I., where he also completed a clinical/research/ interventional fellowship in Cardiology.
Dr. Gray is also a member of numerous professional organizations, including as a fellow in both the Society for Cardiovascular Angiography and Interventions and the American College of Cardiology.
James May, MD
The University of SydneyBOARD MEMBER
Carlos I. Mena, MD
Yale School of MedicineBOARD MEMBER
Dr. Carlos Mena, a native of Medellin, Colombia, is a graduate of the University of Antioquia School of Medicine. He began his postgraduate training at Yale University where he completed his internship and residency in addition to his Cardiology and Interventional Cardiology Fellowships. With a strong desire to provide quality clinical research, Dr. Mena leads many studies in his duty as Principal Investigator.
His hard work and dedication has been recognized as he earned both the John W. Brackett Award for Resident Teacher and the Ralph I. Horwitz Research in Residency Award. In addition to his busy practice, Dr. Mena is a well published physician with a wide range of article publications and book chapters through the contribution of his expertise in Oxford American Handbook of Cardiology.
Dr. Mena served as a Course Director for New Cardiovascular Horizons 2012 and is actively involved in local, national and international conferences through his many diverse presentations. He maintains many professional associations including the Society of Vascular Medicine, American Heart Association, Fellow of Society Cardiac Angiography and Intervention (F.S.C.A.I.) and Fellow of the American College of Cardiology (F.A.C.C.). Dr. Mena is Board Certified in Internal Medicine, Echocardiography, Cardiovascular Disease, and Interventional Cardiology.
Claudio J. Schonholz, MD
Medical University South CarolinaBOARD MEMBER
Dr. Schonholz was born in Buenos Aires, Argentina in 1956. He attended the National College of Buenos Aires, then graduated with Honors from the School of Medicine at the University of Buenos Aires in 1980. After finishing his Residency in Diagnostic Radiology, he completed a fellowship in Vascular and Interventional Radiology at the Centre Cardiologuique du Nord in Paris, France with Professor Michel Tonnelier and Dr. Francis Besse. At the time that Digital Substraction Angiography (DSA) was flourishing.
Dr. Schonholz built a private practice in his hometown with a multidisciplinary team of interventional cardiologists and interventional neurosurgeons. He and his colleague, Luis Augusto Lemme Plaghos, introduced many neurointerventional procedures in Argentina, including brain AVM embolization with glue, brain aneurysm coil embolization and carotid angioplasty.
In 1989 Dr. Schonholz met Dr. Juan Carlos Parodi, a vascular surgeon who was working in a small private hospital nearby. They discussed Dr. Parodi's project of using stent graft for the treatment of high risk patients with abdominal aortic aneurysms, as well as Dr. Schonholz work with carotid angioplasty. As an experienced vascular surgeon and knowing the potential risks of distal embolization during carotid PTA, Dr. Parodi recommended quitting that “very dangerous procedure” and he invited Dr. Schonholz to join his stent graft project. At that time animal studies were taking place in Buenos Aires and San Antonio, Texas with Dr. Julio Palmaz.
In September 1990 the first human case of abdominal aortic aneurysm treated with stent graft was performed at the Buenos Aires Cardiovascular Institute. This innovative and minimal invasive technique completely changed the way vascular surgery is practice, as well as Dr. Schonholz's approach to patient care.
The stent graft technique attracted the attention of the medical community and Dr.Parodi and Dr. Schonholz's team was invited to perform and teach this new operation around the world. In October 1991 the Argentinean team was invited by Dr. Michel Henry and Dr. Max Amor to Nancy, France for a live case demonstration during the 2nd International Course of Peripheral Vascular Intervention. In December 1992, they went to the Montefiore Medical Center at Albert Einstein University in New York and performed the first stent graft procedure in the United States with Dr. Frank Veith and Dr. Michael Marin.
In the mid 1990s, Dr. Schonholz restarted discussions with Dr. Parodi about carotid angioplasty that lead to the development of cerebral protection devices that include a filter and the flow reversal technique for carotid artery stenting.
During the year 2000, he was invited to join the Department of Radiology at Louisiana State University in Shreveport and became Director of Vascular and Interventional Radiology. In January 2004, Dr. Schonholz moved to Charleston, SC and joined the MUSC Department of Radiology and the Heart & Vascular Center.
Craig M. Walker, MD
Cardiovascular Institute of the SouthBOARD MEMBER
Dr. Craig Walker, a native of Bourg, Louisiana, is a graduate of Nicholls State University in Thibodaux, Louisiana and LSU School of Medicine in New Orleans. He began his postgraduate training with an internship and residency at Lafayette Charity Hospital in Lafayette, Louisiana. He continued his training with a cardiology fellowship at Ochsner Foundation Hospital in New Orleans and a research fellowship at Harvard Medical School in Boston, Massachusetts.
In 1983, Dr. Walker returned to south Louisiana to establish the Houma Heart Clinic as a center for the development of new and improved techniques for the treatment of both coronary and peripheral arterial disease. The clinic grew to be Cardiovascular Institute of the South, a world-renowned practice with 37 physicians and nearly 500 team members in 13 cities through south Louisiana.
Dr. Walker co-founded one of the largest peripheral conferences in the nation, New Cardiovascular Horizons, to educate and train medical professionals on the latest techniques and technology. He also maintains the distinct title of primary investigator for several cardiovascular and peripheral devices. Through his extensive knowledge and research in peripheral vascular disease (PVD), Dr. Walker provides educational training courses to other physicians from around the world.
Rodney A. White, MD
Harbor UCLA Medical CenterBOARD MEMBER
Dr. Rodney White is a Professor of Surgery at the UCLA School of Medicine, as well as Vice Chairman of Research, Vascular Surgery Division Chief, and Director of the Vascular Surgery Fellowship Program at Harbor-UCLA Medical Center. Dr. White graduated with honors from Syracuse University where he played football. He graduated with Alpha Omega Alpha honors from the State University of New York in Syracuse. He completed his general surgery residency and Vascular Surgery Fellowship at Harbor-UCLA Medical Center. Dr. White is widely recognized both nationally and internationally for his research in the field of endovascular surgery.
He currently has over a dozen research grants, and is the principal investigator for several national endovascular studies. Considered a pioneer in endovascular surgery, Dr. White spearheaded the animal testing and first human deployment of the Aneurx aortic stent graft at Harbor UCLA alongside Dr. Thomas Fogarty in 1996. Dr. White is the editor of 12 surgical textbooks, including Vascular Surgery: Basic Science and Clinical Correlations. He has authored over 230 publications and 115 book chapters. He has mentored 19 postgraduate fellows in vascular surgery. Dr. White is currently focusing on endovascular applications for carotid disease and thoracic aneurysms.
Boston ScientificINDUSTRY MEMBER
John Crowley has over 25 years of experience in the medical device and consumer marketing and sales fields. He is currently the Vice President and General Manager for the Interventional Oncology franchise within the Peripheral Interventions division at Boston Scientific which consists of Peripheral Embolization, Non-Vascular Interventions, and Vena Cava Filters.
John joined Boston Scientific in 1993 where he has held positions of increasing responsibility. Prior to joining Boston Scientific, John worked at Proctor & Gamble Inc. for six years holding positions in sales and marketing management.
Mr. Crowley has a Marketing degree from the University of Massachusetts. He currently serves on the Board of International Society of Endovascular Specialists, is a member of the American Marketing Association, and has been involved in youth coaching for both basketball and soccer.
John D. McDermott
Endologix, Inc.INDUSTRY MEMBER
John McDermott is Chairman and Chief Executive Officer of Endologix. He has over 25 years of executive management, sales, marketing, and finance experience in the cardiovascular medical device industry. Prior to Endologix, he served as President of Bard Peripheral Vascular, a division of C.R. Bard, Inc.
Mr. McDermott previously held various senior management and executive positions in global sales and operations, research and development, manufacturing, marketing, and finance at C.R. Bard, Inc., and in the medical device division of IMPRA, INC., prior to its acquisition by C.R. Bard. He has a BS in Finance from Arizona State University and an MBA from Western International University.